GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!

Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants We were having cocktails at a fancy restaurant last night with a hedge fund manager, who manages...

GeoVax Labs (GOVX) JP Morgan 2024 Healthcare Conference Transcript.

ILLUSTRATION 3 |MISSION AND STRATEGY Our mission: One is to innovate. The other one is to differentiate. The other one is to accelerate and finally...

Revive Therapeutics (RVVTF) $0.02, Explores the Use of Bucillamine for Long COVID.

Bucillamine is one of the most amazing drugs (in our opinion), which was repurposed from its original use as an anti-inflammatory for use with...

Adding GeoVax (GOVX) $3.32 to Reverse Stock Split Watch List.

Okay, Here's Our First Name for the Reverse Stock Split, Watch List. We'll Venture to Have 10 Names Added to Watch List Within 30...

Adding Geovax (GOVX) to 2024 Biotech Watch List.

GEOVAX (GOVX) $0.32 We added this to the Watch List earlier in the week and then AFTER speaking to CEO David Dodd and the Head...

Bridging the Immunity Gap: An In-Depth Conversation with GeoVax’s (GOVX) CEO, David Dodd

In an era of rapid scientific development, the pharmaceutical industry constantly evolves to meet new challenges and seize emerging opportunities. GeoVax, a biotechnology company...

YIKES! New Form of Antimicrobial Resistance Discovered – One of the World’s Greatest Health...

A new mechanism has been discovered that enables bacteria to take up nutrients from their human host and bypass antibiotic treatment. This new form...

Provention Biosciences (PRVB) Enters the Danger Zone.

Chart Looks Beautiful - But Nervous is why, we use soft and dry. LIVE QUOTE We'll be short and sweet. We make no prediction as for...

VERU (VERU) $6.66, Goes Poof.

Veru Provides Update on FDA Advisory Committee Meeting Market Cap Plunges from $1.9 Billion to $540 Million. "In the long history of drug trials for patients...
Dr John Fahy UCSF

Revive Therapeutics (RVVTF) Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company...

Latest article

Cardiol Therapeutics (CRDL) May 2025 Presentation.

Click here to open. RELATED: Cardiol’s (CRDL) Game-Changing Solution for Heart Inflammation? | David Elsley CEO – Video Interview

Nice Bounce on Alkaline Water (WTER) up 81%.

Well now that ain't bad, up 81%! Our outlook on The Alkaline Water Company, our "comeback of the decade" story, is "let's see what...

Zomedica Corp (ZOMDF) $0.05

Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is headquartered in Ann Arbor, Michigan. Initially listed on the TSX Venture...